Biogen said Monday that it will cut the wholesale acquisition cost of Aduhelm by about 50% next month. STEVEN SENNE/AP FILE
Biogen is slashing the price of its Alzheimer’s treatment in half months after it debuted to widespread criticism for an initial cost that could reach…
